$SMTI News

HC Wainwright & Co. Downgrades Sanara MedTech to Neutral, Lowers Price Target to $35

Sanara MedTech (SMTI) Stock Gets Fair Value Bump As Analysts Back Wound Care Growth

Sanara Medtech Ends Previously Announced Services Agreement With The Catalyst Group; Not Obliged To Pay Penalty Over Agreement Termination

Sanara MedTech (SMTI) Q1 2026 Earnings Transcript

How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put

Sanara MedTech: From Cash Burner To Profitable Growth

Sanara MedTech Inc. Q1 2026 Earnings Call Summary

Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Sanara MedTech Inc. (SMTI) Q1 2026 Earnings Call Transcript

Transcript: Sanara MedTech Q1 2026 Earnings Conference Call

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Sanara MedTech Sees Q2 Sales $28.500M-$29.500M vs $28.650M Est

Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M vs $117.300M Est

Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate

How Sanara MedTech (SMTI) Is Reframing Its Growth Story Around A Steady US$34 Target

Sanara MedTech (SMTI) Q4 2025 Earnings Transcript

What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?

How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions

Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32

Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026